Back to top

Tale of the Tape

Zacks Equity Research

Will Antares Pharma (ATRS) Continue to Surge Higher?
September 27, 2016

Trades from $3

As of late, it has definitely been a great time to be an investor in Antares Pharma Inc. . The stock has moved higher by 39.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider ATRS’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as ATRS has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>